XNAS
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-21 | FY 2025 | — | -0.18 | — | $37.9M | — | -7.90% | -5.00% | -12.23% |
| 2024-08-14 | H1 2024 | — | 0.01 | — | $12.6M | — | +0.00% | +3.54% | +14.69% |
| 2023-08-04 |
| H1 2023 |
| — |
| 0.05 |
| — |
| $29.2M |
| — |
| — |
| — |
| — |
| 2023-04-19 | FY 2022 | — | 0.15 | — | $64.9M | — | — | — | — |
Showing last 4 quarters.